Original scientific paper

https://doi.org/10.5599/admet.1022

Drug-like Properties and Fraction Lipophilicity Index as a combined metric

Anna Tsantili-Kakoulidou ; Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece
Vassilis Demopoulos ; Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece

Abstract

Fraction Lipophicity Index (FLI) has been developed as a composite drug-like metric combining logP and logD in a weighted manner. In the present study an extended data set confirmed the previously established drug-like FLI range 0-8 using two calculation systems for logP /logD assessment, the freeware MedChem Designer and ClogP. The dataset was split into two classes according to percentage of fraction absorbed (%FA) - class 1 including drugs with high to medium absorption levels and class 2 including poorly absorbed drugs. The FLI and FLI© (ClogP based FLI) drug-like range covers 93% and 90 % of class 1 drugs, respectively. The dependence of the degree of ionization to intrinsic lipophilicity within the FLI (FLI©) drug-like range as well as the inter-relation between the other Ro5 properties (Mw, HD, HA) was explored, so as to define drug-like / non drug-like combinations as a safer alternative to single properties for drug candidates’ prioritization. In this sense we propose a combined metric of Mw and number of polar atoms (Mw/NO) to account for both size and polarity. Setting the value 50 as cut off, a distinct differentiation between class 1 and class 2 drugs was obtained with Mw/NO>50 for more than 70% of class 1 drugs, while the opposite was observed for class 2 drugs.

Keywords

drug-likeness; oral drugs; Fraction Lipophilicity Index; Rule of 5; Molecular weight; Polar atoms

Hrčak ID:

263568

URI

https://hrcak.srce.hr/263568

Publication date:

8.10.2021.

Visits: 1.044 *